Grace A. Beloumou
Yaounde, CE, Cameroon
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Brief communication: virological response and drug resistance patterns among men who have sex with men in Yaoundé-Cameroon.
Journal: AIDS research and therapy
Published: February 18, 2026
Efficacy of dolutegravir-based therapy in achieving virological suppression in PLHIV in low- and middle-income countries: real-world evidence from a large clinical cohort in Cameroon.
Journal: BMC infectious diseases
Published: December 05, 2025
Interest in long-acting injectable ART among adolescents with perinatally acquired HIV in Cameroon: Implications for implementation in developing countries.
Journal: PLOS global public health
Published: November 25, 2025
Hepatitis B immune escape and drug resistance mutations among blood donors in Gabon during the year 2022.
Journal: Scientific reports
Published: October 30, 2025
Low burden of clinically relevant anaemia and thrombocytopenia among adolescents living with HIV receiving tenofovir/lamivudine plus dolutegravir: the CIPHER-ADOLA study in Cameroon.
Journal: AIDS research and therapy
Published: July 10, 2025
Diagnostic Concordance of Two- and Three-Gene SARS-CoV-2 Molecular Assays in Cameroon: Implications for Efficient Pandemic Response in Low- and Middle-Income Countries.
Journal: Journal of clinical laboratory analysis
Published: May 17, 2025
Plasma Viral Load of 200 Copies/mL is a Suitable Threshold to Define Viral Suppression and HIV Drug Resistance Testing in Low- and Middle-Income Countries: Evidence From a Facility-Based Study in Cameroon.
Journal: Journal of the International Association of Providers of AIDS Care
Published: December 23, 2024
Evaluation of the concordance between nasopharyngeal and oropharyngeal swabs in the detection of COVID-19.
Journal: Journal of public health in Africa
Published: December 19, 2024
HIV-1 cross-resistance to second-generation non-nucleoside reverse transcriptase inhibitors among individuals failing antiretroviral therapy in Cameroon: implications for the use of long-acting treatment regimens in low- and middle-income countries.
Journal: JAC-antimicrobial resistance
Published: November 05, 2024
Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries.
Journal: Viruses
Published: October 23, 2024
Disparities in anti-SARS-CoV-2 reactivity according to vaccines administered in the era of omicron in Cameroon: Lessons for future outbreak response.
Journal: PLOS global public health
Published: October 08, 2024
Last Updated: 09/26/2026